The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II study of  a novel neoadjuvant chemotherapy (NAC) for breast cancer (BC).
Miguel E. Albino
No relevant relationships to disclose
Fernando Cabanillas
No relevant relationships to disclose
Orestes Antonio Pavia
No relevant relationships to disclose
Margarita Bruno
No relevant relationships to disclose
Miguel M. Echenique
No relevant relationships to disclose
Victor Carlo
No relevant relationships to disclose
Luisa Vanessa Marcial
No relevant relationships to disclose